January/February 1999 Vol 17 No 1/2 ISSN 1321-571X

Contents
This month Novartis’ promotion of Zaditen (ketotifen).
News MaLAM International editions now available via E-mail /www for free.

Novartis promotes Zaditen (ketotifen) in Mexico for asthma.

This month’s edition questions Novartis about the promotion of an antihistamine for asthma in Mexico. Novartis was formed in 1996 from the merger of Sandoz and Ciba Giegy.

A copy of the advertisement appears at the end of this page.

MaLAM International editions now available via E-mail / www for free.

From January 1999 MaLAM International editions are available free, but in English only, via two electronic formats.

• The first format is E-mail messages with links to the MaLAM editions on the MaLAM Web site.
• The second format is E-mail text only messages for subscribers who have access to E-mail but not the www.

We hope that most of our current subscribers will transfer to using one or other of the electronic formats so as to reduce our postage and handling costs. We also hope that making our international editions free will enable us to reach a wider audience. Please notify all your contacts who might be interested and have access to E-mail that this free service is now available. We have a third hope. We hope that a significant percentage of free subscribers will pay annual MaLAM membership fees so as to cover MaLAM’s costs.

To subscribe:

If you have access to E-mail and to the www then please E-mail mintwww-request@camtech.net.au with the word "subscribe" in the text of your message without the quotation marks and with no other words in the message.

If you have access to E-mail but not to www then please E-mail: mintemail-request@camtech.net.au with the word "subscribe" in the text of your message without the quotation marks and with no other words in the message.

Subscriptions to the paper format International editions will continue to be available for an annual subscription fee as before.